Back to search

University of Washington

Patient-reported Clinical Care Experiences while Navigating the Progression of Dysferlinopathy (Limb-Girdle Muscular Dystrophy 2B/R2)

Abstract

dc:description.abstract

Dysferlinopathy is an ultra-rare, autosomal recessive form of limb-girdle muscular dystrophy (LGMD) with no existing treatments or disease-specific clinical care guidelines. Efforts have been made to prepare for future interventional trials of dysferlinopathy through preclinical research, natural history studies, outcome measure development, diagnostic standardization, and a disease-specific global patient registry known as the Dysferlin Registry. However, activities to de-risk drug development programs for the disease have neglected to explore the clinical experiences of individuals with the condition. Knowing what matters most to individuals with dysferlinopathy surrounding their clinical management can inform key opinion leaders as they develop the first standards of care guidelines for the condition. Here, we explore themes from interviews with eight participants through a qualitative, phenomenological framework with key findings suggestive of the need to educate the clinical communities, humanize clinical approaches, customize care, and utilize trauma-informed clinical communication with the dysferlinopathy patient community, facilitating productive clinical engagement.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Emmons, Sarah Shira
Advisor dc:contributor.advisor
  • Edwards, Todd

Subjects

dc:subject × 8

Rights

dc:rights
Statement dc:rights
  • none
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/48739

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Emmons, Sarah Shira. Patient-reported Clinical Care Experiences while Navigating the Progression of Dysferlinopathy (Limb-Girdle Muscular Dystrophy 2B/R2). 2022. http://hdl.handle.net/1773/48739